Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review
Xian-Wen Liang, Bing Liu, Jia-Cheng Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10

Showing 10 citing articles:

Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity
Imane El Meouche, Paras Jain, Mohit Kumar Jolly, et al.
Translational Oncology (2024) Vol. 49, pp. 102069-102069
Closed Access | Times Cited: 5
MicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R/PI3K/AKT pathway
Chikondi Jassi, Wei-Wen Kuo, Yu-Chun Chang, et al.
Translational Oncology (2024) Vol. 50, pp. 102125-102125
Open Access | Times Cited: 4
Molecular Precision Medicine: Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions Between Lidocaine and Rocuronium/Propofol/Paracetamol
Abigail Silva, Joana Mourão, Nuno Vale
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1506-1506
Open Access
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer
Alice Carrier, Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, et al.
Research Square (Research Square) (2025)
Open Access
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies
Sravani Ramisetty, Ayalur Raghu Subbalakshmi, Siddhika Pareek, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3337-3337
Open Access | Times Cited: 2
CMINNs: Compartment model informed neural networks — Unlocking drug dynamics
Nazanin Ahmadi Daryakenari, Shupeng Wang, George Em Karniadakis
Computers in Biology and Medicine (2024) Vol. 184, pp. 109392-109392
Open Access | Times Cited: 1
Metabolic challengers selecting tumor-persistent cells
Caterina Mancini, Giulia Lori, Erica Pranzini, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 3, pp. 263-276
Open Access | Times Cited: 3
Exploring the multifaceted antitumor activity of axitinib in lung carcinoids
Monica Oldani, Maria Celeste Cantone, Germano Gaudenzi, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Investigate the relationship between Bacillus coagulans and its inhibition of chemotherapy‐induced lung cancer resistance
Yu‐Shan Ting, Yi‐Shiuan Wang, En‐Chi Liao, et al.
Biotechnology and Applied Biochemistry (2024)
Closed Access
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer
Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, Tristan Gicquel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top